Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Heike J. Wobst
Observed names:
Heike J Wobst,
Heike Wobst,
Wobst, Heike Julia
Institution:
Jnana Therapeutics (United States)
Observed institutions:
Tufts University,
Max Delbrück Center,
University of Oxford,
Jnana Therapeutics (United States),
AstraZeneca (United States)
ORCID:
0000-0002-9041-3241
Observed ORCID:
0000-0002-9041-3241
OpenAlex ID:
A5006937919
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
2010
·
Jan Bieschke
, Jenny Russ
, et al.
·
Proceedings of the National Academy of Sciences
·
1,050
A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
2021
·
Dean G. Brown
, Heike J. Wobst
·
Journal of Medicinal Chemistry
·
340
The green tea polyphenol (−)‐epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios
2014
·
Heike J. Wobst
, Apurwa Sharma
, et al.
·
FEBS Letters
·
207
PDF
Clinical development times for innovative drugs
2021
·
Dean G. Brown
, Heike J. Wobst
, et al.
·
Nature Reviews Drug Discovery
·
200
The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
2020
·
Heike J. Wobst
, Korrie L. Mack
, et al.
·
Medicinal Research Reviews
·
90
Developmental Regulation of KCC2 Phosphorylation Has Long-Term Impacts on Cognitive Function
2019
·
Yvonne E. Moore
, Leslie C. Conway
, et al.
·
Frontiers in Molecular Neuroscience
·
58
PDF
The small molecule CLP257 does not modify activity of the K+–Cl− co-transporter KCC2 but does potentiate GABAA receptor activity
2017
·
Ross A Cardarelli
, Karen Jones
, et al.
·
Nature Medicine
·
56
Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia
2019
·
Dean G. Brown
, James Shorter
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
53
Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research
2019
·
Dean G. Brown
, Heike J. Wobst
·
Journal of Medicinal Chemistry
·
47
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy
2025
·
Mari Aikio
, Hana M. Odeh
, et al.
·
Cell Reports
·
34
Truncation of the TAR DNA-binding protein 43 is not a prerequisite for cytoplasmic relocalization, and is suppressed by caspase inhibition and by introduction of the A90V sequence variant
2017
·
Heike J. Wobst
, Louise Delsing
, et al.
·
PLoS ONE
·
29
PDF
Inactive USP14 and inactive UCHL5 cause accumulation of distinct ubiquitinated proteins in mammalian cells
2019
·
Jayashree Chadchankar
, Victoria Korboukh
, et al.
·
PLoS ONE
·
28
PDF
Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS In vitro
2017
·
Heike J. Wobst
, Steven S. Wesolowski
, et al.
·
Frontiers in Molecular Neuroscience
·
27
PDF
Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy
2017
·
Heike J. Wobst
, Franziska Denk
, et al.
·
Scientific Reports
·
20
PDF
SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine
2024
·
Heike J. Wobst
, Andreu Viader
, et al.
·
JCI Insight
·
19
PDF
Identification of a Core Amino Acid Motif within the α Subunit of GABAARs that Promotes Inhibitory Synaptogenesis and Resilience to Seizures
2019
·
Anna J. Nathanson
, Yihui Zhang
, et al.
·
Cell Reports
·
19
PDF
Promiscuity of in Vitro Secondary Pharmacology Assays and Implications for Lead Optimization Strategies
2019
·
Dean G. Brown
, Graham F. Smith
, et al.
·
Journal of Medicinal Chemistry
·
18
Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau−/− mice
2017
·
Mariana Vargas-Caballero
, Franziska Denk
, et al.
·
Frontiers in Neuroscience
·
17
PDF
Analysis of orphan designation status for FDA approved drugs, and case studies in oncology, neuroscience and metabolic diseases
2023
·
Dean G. Brown
, Heike J. Wobst
·
Bioorganic & Medicinal Chemistry
·
8
A Small Molecule Slc6a19 Inhibitor Increases Urinary Phenylalanine Excretion and Reduces Its Pathogenic Plasma Accumulation in a Phenylketonuria Mouse Model
2023
·
Heike Wobst
, Ryan Hollibaugh
, et al.
·
Molecular Genetics and Metabolism
·
5
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy
2025
·
Mari Aikio
, Hana M. Odeh
, et al.
·
Cell Reports
·
4
JNT-517, a first-in-class SLC6A19 inhibitor for the treatment of phenylketonuria, enhances urinary excretion of phenylalanine in healthy volunteers
2024
·
Andreu Viader
, John Throup
, et al.
·
Molecular Genetics and Metabolism
·
2
A survey of the clinical pipeline in neuroscience
2021
·
Dean G. Brown
, Heike J. Wobst
·
Bioorganic & Medicinal Chemistry Letters
·
1
Effects of acute inhibition of solute carrier family 6 member 19 on plasma and brain amino acid levels and on neurotransmitters in a mouse model of phenylketonuria
2026
·
Heike Wobst
, Ryan Philbin
, et al.
·
Molecular Genetics and Metabolism
Abstract 4015 RAPID – Photoaffinity-based High-throughput Ligand Discovery in Cells
2026
·
Justin Rettenmaier
, Matthew Labenski
, et al.
·
Journal of Biological Chemistry
Show more works
View as search
Works count:
28
Citation count:
2,331
H-index:
17
I10-index:
18
Year
Topic
Type